Manufacturing Chemist, 7 September 2022
The Coming of Age of Amorphous Solid Dispersions
Pharma's Almanac, 26 October, 2018
Although the majority of new drug candidates suffer from poor solubility and bioavailability, oral solid dosage forms remain the preferred route of administration due to their ease of use and convenience for patients and caregivers. In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies for enhancing the dissolution of challenging APIs.
Topics covered in the article: